CN102552323B - 加速皮肤修复与再生的药物及其制备方法和应用 - Google Patents
加速皮肤修复与再生的药物及其制备方法和应用 Download PDFInfo
- Publication number
- CN102552323B CN102552323B CN2012100136318A CN201210013631A CN102552323B CN 102552323 B CN102552323 B CN 102552323B CN 2012100136318 A CN2012100136318 A CN 2012100136318A CN 201210013631 A CN201210013631 A CN 201210013631A CN 102552323 B CN102552323 B CN 102552323B
- Authority
- CN
- China
- Prior art keywords
- stem cells
- skin
- regeneration
- medicine
- culture fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims description 38
- 230000008929 regeneration Effects 0.000 title abstract description 56
- 238000011069 regeneration method Methods 0.000 title abstract description 56
- 230000008439 repair process Effects 0.000 title abstract description 12
- 229940079593 drug Drugs 0.000 title description 13
- 210000003491 skin Anatomy 0.000 claims abstract description 183
- 210000002514 epidermal stem cell Anatomy 0.000 claims abstract description 128
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 49
- 210000002615 epidermis Anatomy 0.000 claims abstract description 33
- 210000004027 cell Anatomy 0.000 claims description 86
- 239000012531 culture fluid Substances 0.000 claims description 81
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 56
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 41
- 230000033667 organ regeneration Effects 0.000 claims description 36
- 239000001506 calcium phosphate Substances 0.000 claims description 26
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 26
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 26
- 239000003937 drug carrier Substances 0.000 claims description 25
- 239000000872 buffer Substances 0.000 claims description 23
- 108010019160 Pancreatin Proteins 0.000 claims description 22
- 238000010494 dissociation reaction Methods 0.000 claims description 22
- 230000005593 dissociations Effects 0.000 claims description 22
- 229940055695 pancreatin Drugs 0.000 claims description 22
- 210000000056 organ Anatomy 0.000 claims description 20
- 230000001133 acceleration Effects 0.000 claims description 17
- 239000000725 suspension Substances 0.000 claims description 15
- 230000029087 digestion Effects 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 102000004142 Trypsin Human genes 0.000 claims description 11
- 108090000631 Trypsin Proteins 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- 239000012588 trypsin Substances 0.000 claims description 11
- 230000001172 regenerating effect Effects 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 43
- 206010052428 Wound Diseases 0.000 abstract description 38
- 102000008186 Collagen Human genes 0.000 abstract description 30
- 108010035532 Collagen Proteins 0.000 abstract description 30
- 229920001436 collagen Polymers 0.000 abstract description 18
- 210000003780 hair follicle Anatomy 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 14
- 230000000250 revascularization Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 210000001185 bone marrow Anatomy 0.000 abstract description 6
- 210000004207 dermis Anatomy 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 description 44
- 239000000243 solution Substances 0.000 description 32
- 210000000130 stem cell Anatomy 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 238000012360 testing method Methods 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 229960004756 ethanol Drugs 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 230000006378 damage Effects 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 230000037311 normal skin Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000036560 skin regeneration Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 229930040373 Paraformaldehyde Natural products 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229920002866 paraformaldehyde Polymers 0.000 description 8
- 102000002734 Collagen Type VI Human genes 0.000 description 7
- 108010043741 Collagen Type VI Proteins 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 230000018044 dehydration Effects 0.000 description 7
- 238000006297 dehydration reaction Methods 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 229920000159 gelatin Polymers 0.000 description 7
- 239000008273 gelatin Substances 0.000 description 7
- 235000019322 gelatine Nutrition 0.000 description 7
- 235000011852 gelatine desserts Nutrition 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 6
- 229940000425 combination drug Drugs 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000003661 hair follicle regeneration Effects 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- 230000017423 tissue regeneration Effects 0.000 description 6
- 230000008733 trauma Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 230000029663 wound healing Effects 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
- 208000028990 Skin injury Diseases 0.000 description 4
- 206010072170 Skin wound Diseases 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 230000012447 hatching Effects 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000000438 stratum basale Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 3
- 101710160107 Outer membrane protein A Proteins 0.000 description 3
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000004292 cytoskeleton Anatomy 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000003364 immunohistochemistry Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000003147 molecular marker Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 3
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 230000003436 cytoskeletal effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000003328 fibroblastic effect Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000007390 skin biopsy Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 241001416149 Ovis ammon Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010081750 Reticulin Proteins 0.000 description 1
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- RZUBARUFLYGOGC-MTHOTQAESA-L acid fuchsin Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=C(N)C(C)=CC(C(=C\2C=C(C(=[NH2+])C=C/2)S([O-])(=O)=O)\C=2C=C(C(N)=CC=2)S([O-])(=O)=O)=C1 RZUBARUFLYGOGC-MTHOTQAESA-L 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229960005143 amobarbital sodium Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229910000394 calcium triphosphate Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 230000009762 endothelial cell differentiation Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000001440 melanophage Anatomy 0.000 description 1
- 210000000716 merkel cell Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000009818 osteogenic differentiation Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000001216 paracrine cell Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- BNHGKKNINBGEQL-UHFFFAOYSA-M sodium;5-ethyl-5-(3-methylbutyl)pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CC(C)CCC1(CC)C(=O)NC(=O)[N-]C1=O BNHGKKNINBGEQL-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940041022 streptomycins Drugs 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- XOSXWYQMOYSSKB-LDKJGXKFSA-L water blue Chemical compound CC1=CC(/C(\C(C=C2)=CC=C2NC(C=C2)=CC=C2S([O-])(=O)=O)=C(\C=C2)/C=C/C\2=N\C(C=C2)=CC=C2S([O-])(=O)=O)=CC(S(O)(=O)=O)=C1N.[Na+].[Na+] XOSXWYQMOYSSKB-LDKJGXKFSA-L 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100136318A CN102552323B (zh) | 2012-01-17 | 2012-01-17 | 加速皮肤修复与再生的药物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100136318A CN102552323B (zh) | 2012-01-17 | 2012-01-17 | 加速皮肤修复与再生的药物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552323A CN102552323A (zh) | 2012-07-11 |
CN102552323B true CN102552323B (zh) | 2013-12-04 |
Family
ID=46399781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100136318A Active CN102552323B (zh) | 2012-01-17 | 2012-01-17 | 加速皮肤修复与再生的药物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552323B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105326862A (zh) * | 2015-11-16 | 2016-02-17 | 深圳爱生再生医学科技有限公司 | 治疗烧伤皮肤的干细胞制剂及其制备方法 |
CN108324993B (zh) * | 2018-01-15 | 2020-11-03 | 朱剑虹 | 一种诱导毛发再生的干细胞复合体、其制备方法及应用 |
CN108588006A (zh) * | 2018-05-10 | 2018-09-28 | 华东理工大学 | 一种用于肝细胞三维培养的生物支架及其制备方法和应用 |
CN109793918B (zh) * | 2018-12-29 | 2021-02-12 | 中国人民解放军总医院 | 可促进大面积创伤毛囊再生的植物组合敷料 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101775366A (zh) * | 2010-02-05 | 2010-07-14 | 中国人民解放军第四军医大学 | 一种含毛囊组织工程皮肤的制备方法 |
-
2012
- 2012-01-17 CN CN2012100136318A patent/CN102552323B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101775366A (zh) * | 2010-02-05 | 2010-07-14 | 中国人民解放军第四军医大学 | 一种含毛囊组织工程皮肤的制备方法 |
Non-Patent Citations (4)
Title |
---|
"人表皮干细胞改良培养及其组织工程皮肤的构建";张彦刚等;《中国美容医学》;20110120;第20卷(第1期);第80页左列倒数第2段倒数第1-2行,右列第2段第2-5行和第82页左列第2段第7-9行 * |
"应用表皮干细胞、间充质干细胞构建符合皮肤及移植实验";林尊文;《中国优秀硕士学位论文全文数据库》;20090501;摘要和第7页2.3.5(2)、(4) * |
张彦刚等."人表皮干细胞改良培养及其组织工程皮肤的构建".《中国美容医学》.2011,第20卷(第1期),第79-82页. |
林尊文."应用表皮干细胞、间充质干细胞构建符合皮肤及移植实验".《中国优秀硕士学位论文全文数据库》.2009,第E059-24页. |
Also Published As
Publication number | Publication date |
---|---|
CN102552323A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Stem cells for skin tissue engineering and wound healing | |
Azari et al. | Effects of transplanted mesenchymal stem cells isolated from Wharton’s jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation | |
Lange-Consiglio et al. | Investigating the efficacy of amnion-derived compared with bone marrow–derived mesenchymal stromal cells in equine tendon and ligament injuries | |
CN102086451B (zh) | 一种皮肤组织工程种子细胞的扩增方法 | |
CN104312970A (zh) | 一种细胞治疗用临床治疗级表皮干细胞应用人类细胞外基质筛选及规模化培养制备方法 | |
CN104263699A (zh) | 细胞移植用临床治疗级真皮多能干细胞规模化制备培养方法 | |
CN105820998A (zh) | 临床回输级细胞治疗用人脂肪干细胞ADSCs分离提取培养方法 | |
CN106255747B (zh) | 来源于滋养层基底层的干细胞及包含其的细胞治疗剂 | |
Yang et al. | Platelet poor plasma gel combined with amnion improves the therapeutic effects of human umbilical cord‑derived mesenchymal stem cells on wound healing in rats | |
CN102552323B (zh) | 加速皮肤修复与再生的药物及其制备方法和应用 | |
CN107073041A (zh) | 糖尿病性皮肤溃疡治疗的多功能性干细胞 | |
WO2024077893A1 (zh) | 联合干细胞和水凝胶生物材料的制备及其在脊髓损伤中的应用 | |
CN108938669B (zh) | 一种用于治疗皮肤损伤的干细胞软膏及其制备方法 | |
CN103550828A (zh) | 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法 | |
CN102161981B (zh) | 一种重组蛋白联合诱导骨髓间充质干细胞转变为汗腺细胞的方法 | |
CN108066750A (zh) | 干细胞及其分泌物用于治疗皮肤烧烫伤的新用途 | |
CA2787894A1 (en) | Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use | |
CN103301153B (zh) | 脐带间质干细胞培养液或由其制得的产物作为制备治疗皮肤创伤的药剂的应用 | |
Kadam et al. | Treatment of gingival recession defect using human umbilical cord mesenchymal stem cells cultured on PCL based bone regenerating scaffold: a randomized controlled clinical study | |
Chunyi | Antler stem cells sustain regenerative wound healing in deer and in rats | |
CN108057131A (zh) | 一种含有干细胞的新型试剂盒 | |
Buckler et al. | 15 State of the global regenerative medicine industry | |
XiaoMing et al. | Human umbilical cord mesenchymal stem cells combined with porcine small intestinal submucosa promote the healing of full-thickness skin injury in SD rats | |
TWI548413B (zh) | 誘導毛囊新生的皮膚萃取物、組合物及其用途 | |
Alves et al. | Mesenchymal stem cell therapy for equine tendinitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120711 Assignee: Hainan Ze Biotechnology Co., Ltd. Assignor: Zhejiang University Contract record no.: 2015460000006 Denomination of invention: Medicine for accelerating skin repair and regeneration, preparation method thereof and application thereof Granted publication date: 20131204 License type: Exclusive License Record date: 20150519 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Hainan Ze Biotechnology Co., Ltd. Assignor: Zhejiang University Contract record no.: 2015460000006 Date of cancellation: 20160509 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |